SCHEMBL8536869

SCHEMBL8536869

CCCc1cc(/C=C2\SC(=S)NC2=O)cc(C(C)(C)C)c1O

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 7/20 0.76
PTGS1 P23219 2/20 0.58
NPC1 O15118 2/20 0.56
NAT1 P18440 2/20 0.56
MEN1 O00255 1/20 0.56
ALDH1A1 P00352 1/20 0.56
LMNA P02545 1/20 0.56
POLB P06746 1/20 0.56
GAA P10253 1/20 0.56
MAPT P10636 1/20 0.56
KMT2A Q03164 1/20 0.56
CISD1 Q9NZ45 1/20 0.53
PIK3CG P48736 1/20 0.52
DNM1 Q05193 1/20 0.48
CTSD P07339 2/20 0.48
PIM1 P11309 1/20 0.47
DYRK1A Q13627 1/20 0.47
PIM3 Q86V86 1/20 0.47
DYRK2 Q92630 1/20 0.47
PIM2 Q9P1W9 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8536872 1.00 PTGS2 (0.76) PTGS2PTGS1NPC1NAT1MEN1
SCHEMBL7768284 0.87 PTGS2 (1.00) PTGS2PTGS1NPC1NAT1MEN1
SCHEMBL8309757 0.87 PTGS2 (1.00) PTGS2PTGS1NPC1NAT1MEN1
SCHEMBL8618544 0.87 PTGS2 (1.00) PTGS2PTGS1NPC1NAT1MEN1
SCHEMBL8535410 0.82 PTGS2 (0.85) PTGS2PTGS1NPC1NAT1MEN1
SCHEMBL8535412 0.82 PTGS2 (0.85) PTGS2PTGS1NPC1NAT1MEN1
SCHEMBL18103059 0.82 CISD1 (0.76) PTGS2NPC1NAT1MEN1ALDH1A1
SCHEMBL18095857 0.82 CISD1 (0.76) PTGS2NPC1NAT1MEN1ALDH1A1
SCHEMBL18095856 0.82 CISD1 (0.76) PTGS2NPC1NAT1MEN1ALDH1A1
SCHEMBL9474485 0.80 PTGS2 (0.62) PTGS2PTGS1NPC1NAT1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0434394-B1 Compounds for treating inflammatory bowel disease LILLY CO ELI (US) 1998-08-05 EP disclosed
WO-1996022772-A1 METHOD FOR TREATING MULTIPLE SCLEROSIS ELI LILLY AND COMPANY (US) 1996-08-01 WO disclosed
EP-0722729-A2 Aryl-substituted rhodanines for treating multiple sclerosis ELI LILLY AND COMPANY (US) 1996-07-24 EP disclosed
US-5387690-A Method of treating inflammatory bowel disease ELI LILLY AND COMPANY (US) 1995-02-07 US disclosed
US-5158966-A Aryl-substituted rhodanine derivatives THE UNIVERSITY OF COLORADO FOUNDATION, INC. (US) 1992-10-27 US disclosed
EP-0500337-A1 Composition containing aryl-substituted rhodanine derivatives for the treatment of type I diabetes UNIVERSITY OF COLORADO FOUNDATION, INC. (US) 1992-08-26 EP disclosed
EP-0434394-A2 Compounds for treating inflammatory bowel disease ELI LILLY AND COMPANY (US) 1991-06-26 EP disclosed